MiMedx To Present Clinical And Scientific Studies At Desert Foot Conference
Dr. Ortega, a former Army Special Forces Officer (Green Beret) and
Dr. Lim will provide an overview of the
During a sponsored hands-on workshop on
The five poster abstracts will report on MiMedx EpiFix and EpiCord allografts, as follows:
William Tettelbach, MD; Shawn Cazzell, DPM; Alexander M. Reyzelman, DPM; Felix Sigal, DPM; Joseph M. Caporusso, DPM; Patrick S. Agnew, DPM: A Prospective, Multicenter, Randomized, Controlled Study Confirming the Efficacy of Dehydrated Human Amnion/Chorion Membrane Allograft in the Management of Diabetic Foot Ulcers William Tettelbach, MD; Shawn Cazzell, DPM; Felix Sigal, DPM; Joseph M. Caporusso, DPM; Patrick S. Agnew, DPM; Jason Hanft, DPM; Cyaandi Dove, DPM: A Multicenter Prospective Randomized Controlled Comparative Parallel Study of Dehydrated Human Umbilical Cord Allograft for the Treatment of Diabetic Foot Ulcers Brandon Brooks, DPM PGY-3; Kevin Pham, DPM PGY-4; Bradley Brooks, DO PGY-2; Brady Brooks, MSII; James Henry, MSII; Charles Kean, DPM; Terria Madison, DPM: Intraoperative Use of Umbilical Cord Allograft in Achilles Tendon Surgery for Postoperative Pain Reduction in Diabetics: A Case Series Brandon Brooks, DPM PGY-3; Bradley Brooks, DO PGY-2; Brady Brooks, MSII; Richa Patel, DPM PGY-2; Anubha Oberoi, DPM PGY-1; Charles Kean, DPM: Concurrent Use of Cyclical Pressure Topical Wound Oxygen Therapy & Umbilical Cord Allograft in a Diabetic with a Pressure Ulceration of the Right Posterior Leg with Exposed Achilles Tendon: A Case Study Jeremy J. Lim, PhD; Jennifer Lei, PhD; Jenn D. Bullard; Anna M. Fallon, PhD; Michelle Massee; Thomas J. Koob, PhD: Evaluation of Dehydrated Human Umbilical Cord Biological Propertiesfor Wound Care and Soft Tissue Healing
MiMedx® is a leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The Company processes the human placental tissue utilizing its proprietary PURION® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization.
Robert P. Borchert, Vice President, Investor Relations, 770-651-9383, firstname.lastname@example.org